Prognostic Implications of Clinical and Imaging Diagnostic Criteria for Myocarditis

Benedikt Bernhard1, Martin E Marxer2, Jan C Zurkirchen2

  • 1Department of Cardiology, University Hospital Bern, Bern, Switzerland; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Insights

The European Society of Cardiology (ESC) criteria are effective for diagnosing myocarditis and predicting patient outcomes. Updated Lake-Louise criteria (LLC) also show prognostic value, highlighting the importance of clinical and cardiac MRI findings.

Area of Science:

  • Cardiology
  • Medical Diagnostics
  • Cardiac Imaging

Background:

  • Current diagnostic criteria for myocarditis vary among major cardiology societies.
  • The prognostic implications of these differing criteria have not been previously compared.

Purpose of the Study:

  • To compare the diagnostic and prognostic value of European Society of Cardiology (ESC) criteria, updated Lake-Louise criteria (LLC), American Heart Association (AHA) probable acute myocarditis (pAM) criteria, and expert consensus criteria for acute myocarditis (AM) and complicated myocarditis (CM).

Main Methods:

  • A cohort of 1,050 patients with suspected myocarditis and available cardiac magnetic resonance (CMR) data were analyzed.
  • Patients without alternative diagnoses were assessed for adherence to various myocarditis diagnostic criteria.
  • The association between diagnostic criteria and adverse composite outcomes (heart failure hospitalization, recurrent myocarditis, sustained ventricular tachycardia, or death) was evaluated.

Main Results:

  • Most patients (89.3%) met ESC criteria, while fewer met LLC (28.5%), pAM (33.9%), AM (20.6%), or CM (7.3%).
  • Adverse events occurred in 15.3% of patients over a median follow-up of 3.4 years.
  • ESC criteria and LLC demonstrated the strongest independent and incremental prognostic value for adverse outcomes, with LLC showing the highest event rates (6.6%).

Conclusions:

  • ESC criteria identify a larger proportion of myocarditis patients in a real-world setting compared to LLC.
  • Both ESC and LLC criteria possess significant independent prognostic value.
  • Integrating clinical assessment (ESC criteria) with CMR findings (LLC) is crucial for accurate myocarditis diagnosis and risk stratification.
Abstract

Related Concept Videos

Myocarditis II: Clinical features and Diagnostic Tests01:27

Myocarditis II: Clinical features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
2
Pericarditis II: Clinical features and Diagnostic Tests01:19

Pericarditis II: Clinical features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
3
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
2
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
2
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
6
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
2